Star Imaging and Path Lab share price
BSE: 544482Healthcare ServicesSmall Cap
STAR IMAGING AND PATH LAB LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2025
Last close ₹71.15down ₹1.35 (1.86%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹72.50.
30 Oct: open ₹71.15, high ₹71.15, low ₹71.15
52-week range of traded prices to 30 Oct 2026
₹46.00Low, 30 Mar 2026₹152.00High, 14 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹124 Cr2,719th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 6.43
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 16.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.18
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,000
Results
Consolidated; ₹ crore.Star Imaging and Path Lab half-yearly results
Half year to Mar 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹43 Crdown 4.11%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹9.23 Crdown 8.14%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 21.3%
Revenue by half year
Peak revenue ₹45 Cr, half year to Sep 2025; lowest ₹43 Cr, half year to Mar 2026
Net profit by half year, a loss in red
| ₹ crore | Sep 2025 | Mar 2026 |
|---|---|---|
| Revenue | 45.2 | 43.3 |
| Net profit | 10.0 | 9.2 |
| Net margin | 22.2% | 21.3% |
Consolidated. The 2 half years from Sep 2025, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026
- Revenue
- ₹89 Cr
- Net profit
- ₹19 Cr
- Net margin
- 21.8%
| ₹ crore | Mar 2026 |
|---|---|
| Revenue | 88.5 |
| Net profit | 19.3 |
| Net margin | 21.8% |
Consolidated. Years to March. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Diagnostic, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Star Imaging and Path Lab PE ratio and valuation
Price to book
At or below today's level on 14% of 237 trading days since Nov 2025.
LowestHighest
Its median1.28Industry median1.67
Star Imaging and Path Lab competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 30 Oct 2026. The table lists the 8 companies closest to Star Imaging and Path Lab in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Chandan HealthcareCHANDAN | 604 | – | – | – | – | – | – | 0.00% |
| Pramodini MedicarePRAMODINI | 235 | – | – | – | – | – | – | 0.00% |
 Aspira Pathlab & DiagnosticsASPIRA | 138 | – | 11.26 | +14.6% | −117.7% | −3.7% | −4.4% | 0.00% |
 Choksi LaboratoriesCHOKSILA | 136 | 62.93 | 5.32 | +10.7% | +45.3% | 8.8% | 9.2% | 0.00% |
 Modern Diagnostic & Research CentreMDRC | 88 | 16.67 | 1.50 | – | – | 9.0% | – | 0.00% |
 Invicta DiagnosticINVICTA | 81 | 16.53 | 1.62 | – | – | 9.8% | 12.2% | 0.00% |
 N.G.IndustriesNGIND | 34 | 17.64 | 1.01 | +2.2% | −74.1% | 5.3% | 3.7% | 3.45% |
 Bandaram Pharma PacktechBANDARAM | 34 | – | 1.26 | +114.5% | – | – | 6.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Star Imaging and Path Lab announcements
Oct 2026
12 Oct · Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Empanelment With MCD
Sep 2026
28 Sep · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Commencement Of Commercial Operations Of CT Scan Facility At Faridabad, Haryana
1 Sep · Web-Link To Access The Annual Report-2025-26
1 Sep · Meeting
Star Imaging and Path Lab share price by year
Each calendar year to 2025.Star Imaging and Path Lab share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 90.95 | – | 147.90 | 90.75 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 18 Aug 2025.
Recent sessions
The 9 trading days to 29 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 29 Oct 2026 | 70.20 | 72.50 | 70.20 | 72.50 | 71.30 | 7,000 |
| 28 Oct 2026 | 74.50 | 75.99 | 74.10 | 74.70 | 74.92 | 5,000 |
| 27 Oct 2026 | 74.04 | 75.00 | 74.04 | 75.00 | 74.52 | 2,000 |
| 26 Oct 2026 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 4,000 |
| 23 Oct 2026 | 77.00 | 77.00 | 74.60 | 74.70 | 75.78 | 5,000 |
| 22 Oct 2026 | 71.75 | 79.00 | 71.75 | 77.00 | 75.41 | 17,000 |
| 21 Oct 2026 | 69.50 | 71.75 | 69.00 | 71.75 | 69.69 | 7,000 |
| 19 Oct 2026 | 78.00 | 78.00 | 62.40 | 69.05 | 70.60 | 45,000 |
| 16 Oct 2026 | 75.56 | 78.00 | 75.56 | 78.00 | 77.64 | 22,000 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 544482
- ISIN
- INE0YG001013
- Industry
- Healthcare Services
- Website
- www.starimaging.in
- CIN
- L85110DL2004PLC126679
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2004
- Registered office
- 4B/4, Tilak Nagar, Near Sant Pura, West Delhi, 110018
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments